Adjuvant Vaginal High-Dose-Rate Afterloading Alone in Endometrial Carcinoma: Patterns of Relapse and Side Effects Following Low-Dose Therapy

By Weiss E.   Hirnle P.   Arnold-Bofinger H.   Hess C.F.   Bamberg M.  

Gynecologic Oncology, Vol. 71, Iss. 1, 1998-10 ,pp. : 72-76

Elsevier

Access to resources Recommend Favorite

Matrix Metalloproteinase-2 (MMP-2) is Associated with the Risk for a Relapse in Postmenopausal Patients with Node-Positive Breast Carcinoma Treated with Antiestrogen Adjuvant Therapy

By Talvensaari-Mattila A.  

Breast Cancer Research and Treatment, Vol. 65, Iss. 1, 2001-01 ,pp. : 55-61

Springer Publishing Company

Access to resources Recommend Favorite

Clarity and Confusion Regarding Adjuvant Radiation Therapy in Early Endometrial Cancer

By Cardenes H.   Randall M.E.  

Gynecologic Oncology, Vol. 75, Iss. 1, 1999-10 ,pp. : 1-3

Elsevier

Access to resources Recommend Favorite

The Effect of Postsurgical Therapy on Stage III Endometrial Carcinoma

By Schorge J.O.   Molpus K.L.   Goodman A.   Nikrui N.   Fuller Jr A.F.  

Gynecologic Oncology, Vol. 63, Iss. 1, 1996-10 ,pp. : 34-39

Academic Press

Access to resources Recommend Favorite

FIGO Stage IIIC Endometrial Carcinoma with Metastases Confined to Pelvic Lymph Nodes: Analysis of Treatment Outcomes, Prognostic Variables, and Failure Patterns Following Adjuvant Radiation Therapy

By Nelson G.   Randall M.   Sutton G.   Moore D.   Hurteau J.   Look K.  

Gynecologic Oncology, Vol. 75, Iss. 2, 1999-11 ,pp. : 211-214

Elsevier

Access to resources Recommend Favorite